AR007767A1 - Nuevos derivados de acidos alfa-hidroxi, su preparacion y utilizacion de dichos derivados o fragmentos de los mismos como antagonistas de receptores de las endotelinas - Google Patents
Nuevos derivados de acidos alfa-hidroxi, su preparacion y utilizacion de dichos derivados o fragmentos de los mismos como antagonistas de receptores de las endotelinasInfo
- Publication number
- AR007767A1 AR007767A1 ARP970101460A ARP970101460A AR007767A1 AR 007767 A1 AR007767 A1 AR 007767A1 AR P970101460 A ARP970101460 A AR P970101460A AR P970101460 A ARP970101460 A AR P970101460A AR 007767 A1 AR007767 A1 AR 007767A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- alkoxy
- group
- derivatives
- hydroxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/80—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- C07D239/96—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
- C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
- C07D251/20—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with no nitrogen atoms directly attached to a ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
- C07D251/22—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to two ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/30—Only oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/38—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/48—Two nitrogen atoms
- C07D251/52—Two nitrogen atoms with an oxygen or sulfur atom attached to the third ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se trata de derivados de ácidos alfa-hidroxicarboxílicos de fórmula (I) donde R es un grupo de fórmula-CO-R1, en la cual R1 tiene los siguientessignificados: a) hidrógeno, b) un grupo succinilimidoxi; c) un grupo heteroaromático de 5m iembros ligados mediante un átomo de nitrógeno, tal comopirrolilo, pirazolilo, imidazolilo o triazolilo, opcionalmente sustituído por uno o dos átomos de halógeno o uno o dos grupos alquilo de 1 a 4 átomos decarbono o uno o dos grupos alcoxi de1 a 4 átomos de carbono; d) un grupo de fórmula (II) en el cual k vale 0, 1 y 2 y p es 1,2,3 y 4, y R9 es C1-C4-alquilo, C3-C7-cicloalquilo, C3-C6-alquenilo, C3-C6 alquinilo o fenilo eventualmente sustituído, con al menos uno de los siguientesradi cales: halógeno, nitro,ciano, C1-C4-alquilo, C1-C4 halogenoalquilo, hidroxi C1-C4-alcoxi, C1-C4- -alquiltio, mercapto, amino, C1-C4-alquilo, C1-C4 dialquilamino; e) R1 tambiénpuede ser un radical OR10, representando R10 alguno de lossiguientes : hidrógeno, el catión de un metal alcalino tal como litio, sodio, potasio, o elcatión de un metal alcalio-térreo tal como calcio, magnesio o bario como también ión alquilamonio o amonio fisiológiamente tolerable; C3-C8cicloalquiloC1 -C8-alquilo, CH2-fenilo, que puede estar sustituido por uno o más de los siguientes radicales: halógeno, nitro, ciano, C1-C4-alquilo, C1-C4-halogenoalquilo, hidroxi, C1-C4-alcoxi, C1-C4-alcoxi, mercapto, C1-C4-alquiltío amino, C1-C4 alquilamino, C1-C4-dialquilamino; un grupo C3-C6-alquenilo o ungrupo C3-C6-alquinilo, pudiendo por su parte estos grupos llevar de uno a cinco átomos de halógeno; R10 puede también ser un radical fenilo, que puede llevarde uno a cinco átomos dehalógeno y/o de u no a tres de los siguientes radicales: nitro, ciano, C1-C4-alquilo, C1-C4-halogenoalquilo, hidroxi, C1-C4-alcoxi,
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19614533A DE19614533A1 (de) | 1996-04-12 | 1996-04-12 | Neue alpha-Hydroxysäurederivate, ihre Herstellung und Verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
AR007767A1 true AR007767A1 (es) | 1999-11-24 |
Family
ID=7791117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP970101460A AR007767A1 (es) | 1996-04-12 | 1997-04-11 | Nuevos derivados de acidos alfa-hidroxi, su preparacion y utilizacion de dichos derivados o fragmentos de los mismos como antagonistas de receptores de las endotelinas |
Country Status (25)
Country | Link |
---|---|
US (1) | US6686369B1 (es) |
EP (1) | EP0892787B1 (es) |
JP (1) | JP2000508326A (es) |
KR (1) | KR20000005369A (es) |
AR (1) | AR007767A1 (es) |
AT (1) | ATE242770T1 (es) |
AU (1) | AU731579B2 (es) |
BG (1) | BG102868A (es) |
BR (1) | BR9708608A (es) |
CA (1) | CA2250757A1 (es) |
CO (1) | CO4900040A1 (es) |
DE (2) | DE19614533A1 (es) |
HR (1) | HRP970198A2 (es) |
HU (1) | HUP9901312A3 (es) |
ID (1) | ID16501A (es) |
IL (1) | IL126350A0 (es) |
NO (1) | NO311801B1 (es) |
NZ (1) | NZ332096A (es) |
PL (1) | PL329241A1 (es) |
SK (1) | SK134498A3 (es) |
TR (1) | TR199802039T2 (es) |
TW (1) | TW425383B (es) |
UA (1) | UA49884C2 (es) |
WO (1) | WO1997038981A1 (es) |
ZA (1) | ZA973097B (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0946524A1 (de) * | 1996-12-18 | 1999-10-06 | Basf Aktiengesellschaft | Heterozyklische carbonsäurederivate, ihre herstellung und verwendung als endothelinrezeptorantagonisten |
US6030975A (en) * | 1997-03-14 | 2000-02-29 | Basf Aktiengesellschaft | Carboxylic acid derivatives, their preparation and use in treating cancer |
DE19726146A1 (de) * | 1997-06-19 | 1998-12-24 | Basf Ag | Neue ß-Amino und ß-Azidopcarbonsäurederivate, ihre Herstellung und Verwendung als Endothelinrezeptorantagonisten |
JP2002507996A (ja) * | 1997-07-03 | 2002-03-12 | デュポン ファーマシューティカルズ カンパニー | 神経学的障害を治療するためのイミダゾピリミジン類およびイミダゾピリジン類 |
DE19743681A1 (de) * | 1997-10-02 | 1999-04-08 | Knoll Ag | Methode zur Verhinderung der Transplantatabstoßung |
JP5187991B2 (ja) | 1997-10-17 | 2013-04-24 | アーク・セラピューティックス・リミテッド | レニン−アンジオテンシン系の阻害剤の使用 |
DE19806438A1 (de) * | 1998-02-17 | 1999-08-19 | Basf Ag | Neue Carbonsäurederivate mit 5-substituiertem Pyrimidinring, ihre Herstellung und Verwendung |
US6124463A (en) * | 1998-07-02 | 2000-09-26 | Dupont Pharmaceuticals | Benzimidazoles as corticotropin release factor antagonists |
US6365589B1 (en) | 1998-07-02 | 2002-04-02 | Bristol-Myers Squibb Pharma Company | Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists |
US7566452B1 (en) | 1999-05-04 | 2009-07-28 | New York University | Cancer treatment with endothelin receptor antagonists |
DE10064797A1 (de) * | 2000-12-22 | 2002-06-27 | Knoll Ag | Orale und parenterale pharmazeutische Formulierung, umfassend eine niedermolekulare Thrombininhibitor-Pro-Pharmakon |
EP1243262B1 (en) | 2001-03-20 | 2006-05-31 | Schwarz Pharma Ag | Novel use of a peptide class of compound for treating non-neuropathic inflammatory pain |
EP1243263B1 (en) | 2001-03-21 | 2002-11-27 | Schwarz Pharma Ag | Novel use of a peptide class of compound for treating allodynia or other different types of chronic or phantom pain |
MXPA06011937A (es) | 2004-04-16 | 2007-01-26 | Sanol Arznei Schwarz Gmbh | Uso de compuestos peptidicos para la profilaxis y el tratamiento de dolor de cabeza cronico. |
EP1604656A1 (en) | 2004-06-09 | 2005-12-14 | Schwarz Pharma Ag | Novel use of peptide compounds for treating amyotrophic lateral sclerosis (ALS) |
BRPI0514721A (pt) | 2004-08-27 | 2008-06-24 | Sanol Arznei Schwarz Gmbh | uso de compostos de peptìdeos para tratar dor de cáncer ósseo, dor induzida por quimioterapia e nucleosìdeo |
KR20080111137A (ko) * | 2006-04-13 | 2008-12-22 | 액테리온 파마슈티칼 리미티드 | 초기 단계 특발성 폐 섬유증을 위한 엔도텔린 수용체 대항제 |
SI2462990T1 (sl) | 2006-06-15 | 2014-04-30 | Ucb Pharma Gmbh | Farmacevtski sestavek, ki obsega lakozamid in levetiracetam, s sinergističnim antikonvulzivnim učinkom |
WO2011022694A2 (en) * | 2009-08-20 | 2011-02-24 | University Of Tennessee Research Foundation, The | Furanopyrimidine cannabinoid compounds and related methods of use |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4035758A1 (de) * | 1990-11-08 | 1992-05-14 | Schering Ag | Substituierte (alpha)-pyrimidinyloxy(thio)- und (alpha)-triazinyloxy(thio)-carbonsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung als mittel mit herbizider, fungizider und pflanzenwachstumsregulierender wirkung |
DE4313412A1 (de) | 1993-04-23 | 1994-10-27 | Basf Ag | 3-(Het)aryl-Carbonsäurederivate, Verfahren und Zwischenprodukte zu ihrer Herstellung |
DE4411225A1 (de) | 1994-03-31 | 1995-10-05 | Basf Ag | Verwendung von Carbonsäurederivaten als Arzneimittel |
DE19533023B4 (de) * | 1994-10-14 | 2007-05-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
-
1996
- 1996-04-12 DE DE19614533A patent/DE19614533A1/de not_active Withdrawn
-
1997
- 1997-04-04 NZ NZ332096A patent/NZ332096A/xx unknown
- 1997-04-04 KR KR1019980708091A patent/KR20000005369A/ko not_active Application Discontinuation
- 1997-04-04 HU HU9901312A patent/HUP9901312A3/hu unknown
- 1997-04-04 US US09/155,944 patent/US6686369B1/en not_active Expired - Fee Related
- 1997-04-04 EP EP97918110A patent/EP0892787B1/de not_active Expired - Lifetime
- 1997-04-04 IL IL12635097A patent/IL126350A0/xx unknown
- 1997-04-04 WO PCT/EP1997/001688 patent/WO1997038981A1/de not_active Application Discontinuation
- 1997-04-04 UA UA98116020A patent/UA49884C2/uk unknown
- 1997-04-04 AU AU26365/97A patent/AU731579B2/en not_active Ceased
- 1997-04-04 BR BR9708608A patent/BR9708608A/pt not_active IP Right Cessation
- 1997-04-04 PL PL97329241A patent/PL329241A1/xx unknown
- 1997-04-04 CA CA002250757A patent/CA2250757A1/en not_active Abandoned
- 1997-04-04 JP JP9536699A patent/JP2000508326A/ja active Pending
- 1997-04-04 TR TR1998/02039T patent/TR199802039T2/xx unknown
- 1997-04-04 AT AT97918110T patent/ATE242770T1/de not_active IP Right Cessation
- 1997-04-04 SK SK1344-98A patent/SK134498A3/sk unknown
- 1997-04-04 DE DE59710272T patent/DE59710272D1/de not_active Expired - Fee Related
- 1997-04-11 CO CO97018892A patent/CO4900040A1/es unknown
- 1997-04-11 HR HR19614533.3A patent/HRP970198A2/xx not_active Application Discontinuation
- 1997-04-11 ZA ZA973097A patent/ZA973097B/xx unknown
- 1997-04-11 AR ARP970101460A patent/AR007767A1/es not_active Application Discontinuation
- 1997-04-12 TW TW086104727A patent/TW425383B/zh not_active IP Right Cessation
- 1997-04-14 ID IDP971242A patent/ID16501A/id unknown
-
1998
- 1998-10-09 NO NO19984717A patent/NO311801B1/no not_active IP Right Cessation
- 1998-10-26 BG BG102868A patent/BG102868A/bg unknown
Also Published As
Publication number | Publication date |
---|---|
AU2636597A (en) | 1997-11-07 |
BG102868A (bg) | 1999-11-30 |
EP0892787A1 (de) | 1999-01-27 |
NO984717L (no) | 1998-10-09 |
ID16501A (id) | 1997-10-02 |
DE19614533A1 (de) | 1997-10-16 |
DE59710272D1 (de) | 2003-07-17 |
CA2250757A1 (en) | 1997-10-23 |
IL126350A0 (en) | 1999-05-09 |
BR9708608A (pt) | 1999-08-03 |
TR199802039T2 (xx) | 1999-01-18 |
HRP970198A2 (en) | 1998-04-30 |
NO984717D0 (no) | 1998-10-09 |
NO311801B1 (no) | 2002-01-28 |
AU731579B2 (en) | 2001-04-05 |
US6686369B1 (en) | 2004-02-03 |
SK134498A3 (en) | 1999-03-12 |
HUP9901312A3 (en) | 2000-06-28 |
NZ332096A (en) | 2000-01-28 |
ATE242770T1 (de) | 2003-06-15 |
PL329241A1 (en) | 1999-03-15 |
UA49884C2 (uk) | 2002-10-15 |
TW425383B (en) | 2001-03-11 |
CO4900040A1 (es) | 2000-03-27 |
ZA973097B (en) | 1998-10-12 |
JP2000508326A (ja) | 2000-07-04 |
KR20000005369A (ko) | 2000-01-25 |
EP0892787B1 (de) | 2003-06-11 |
HUP9901312A2 (hu) | 1999-08-30 |
WO1997038981A1 (de) | 1997-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR007767A1 (es) | Nuevos derivados de acidos alfa-hidroxi, su preparacion y utilizacion de dichos derivados o fragmentos de los mismos como antagonistas de receptores de las endotelinas | |
GR1000371B (el) | Μεθοδος παρασκευης παραγωγων πυριμιδινης. | |
NO20062263L (no) | Fremgangsmate for fremstilling av kalsiumsaltet til Rosuvatatin, (E)-7-[4-(4-fluorfenyl) -6-isopropyl-2-[metyl (metylsulfonyl) amino]pyrimidin -5-yl] (3R, 5S)-3,5-dihydroksyhept-6-ensyre samt | |
ES8702400A1 (es) | Procedimiento para la obtencion de acidos 7-amino-1-ciclopropil-6,8-dihalogeno-1,4-dihidro-4-oxo-3-quinolincarboxilico | |
WO2003084936A8 (en) | Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological | |
EA200401533A1 (ru) | Способ получения росувастатина | |
DK1485359T3 (da) | Natriumkanalblokkere | |
EA200000826A1 (ru) | Галоидированные производные амидиноаминокислот, применимые в качестве ингибиторов no-синтазы | |
EA200000804A1 (ru) | Мета-азациклические соединения аминобензойной кислоты и их производные, являющиеся ингибиторами интегрина | |
CO4770961A1 (es) | Nuevos derivados de aminoacido y su obtencion | |
AR245933A1 (es) | Procedimiento para preparar compuestos de 4-(3-hidroxifenil)metil-3-alquil-n-alquilpiperidina y sus sales. | |
YU160189A (sh) | Anelirani derivati tetrahidropiridinocetne kisline in postopki za njihovo pripravo | |
ES476658A1 (es) | Procedimiento para preparar derivados de sulfonamido-piridi-na | |
AU3415599A (en) | Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor agents | |
ES8107142A1 (es) | Un procedimiento para la preparacion de acetofenonas substi-tuidas | |
NO20003601L (no) | Nye naftyl-substituerte og anilid-substituerte sulfonamider | |
CO4900039A1 (es) | Nuevos derivados de acidos carboxilicos, su obtencion y aplicacion | |
FI955498A (fi) | Nipekotiinihappojohdannaisia hyytymistä estävinä aineina | |
BR0013346A (pt) | Método para inibir polimerização prematura de monÈmero etilenicamente insaturado e composição | |
EA200000628A1 (ru) | Ингибиторы металлопротеаз матрикса | |
KR920002536A (ko) | 피롤 유도체 | |
DE69429642D1 (de) | Lactol-Derivate, als Cathepsin L Inhibitoren | |
CO4930270A1 (es) | Derivados heterociclicos de acido carbonico su produccion y aplicacion como antagonistas de receptores deendotelina | |
AR247879A1 (es) | Procedimiento para preparar nuevos derivados de 4-acilaminopirrolidina y sus sales farmaceuticamente aceptables | |
ZA951013B (en) | Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |